One of the difficulties encountered in intravenous therapy with streptokinase as a plasminogen activator is the early development of antibodies during treatment which, in addition to neutralizing the activator, may also cause sensitivity reactions. The presence of pre-formed antibodies markedly influences the dose of activator necessary to achieve a satisfactory thrombolytic state in plasma. These factors are also of importance if intrathecal streptokinase is used to induce a fibrinolytic state in the cerebrospinal fluid (Stewart, 1964) . A method has been devised, therefore, for the detection and measurement of such antibodies, by measuring their effect on streptokinase in a semi-purified system where the lysis time under controlled conditions is known. A standardized bovine fibrin clot is made incorporating a known amount of streptokinase and human plasminogen, the lysis time of which is predictable. Addition of cerebrospinal fluid to the mixture before clotting will lengthen the lysis time if antibodies to streptokinase are present. Two difficulties have to be overcome. First, there must be no streptokinase or other activator in the cerebrospinal fluid as this will alter the lysis time of the system. Secondly, the amount of plasminogen in the system might be altered by the addition of a plasminogen-rich cerebrospinal fluid. This is overcome by the enriching of the system with excess plasminogen so that the largest amount likely to be added in any cerebrospinal fluid will be insignificant. The effect of varying the plasminogen content is shown in 
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LYSIS TIME C min) -Sherry units. The largest amount of plasminogen 1j to be added in any cerebrospinal fluid will be very s compared with this change and can therefore be ignc A concentration of 1 Sherry unit of plasminogen ir system appears to be suitable. Figure 2 shows the effect of varying the streptoki concentration over a wide range while keeping plasn gen constant. It will be seen that if a concentratio 0 5 units of streptokinase is used this will give a venient lysis time of about 20 min., while permitti large increase of lysis time with small reduction streptokinase. A small amount of added plasmin therefore produces no change in lysis time, while a s inhibitory effect on the streptokinase will produ large change. LYSIS TIME Cmin.)
The reagents used are as follows:
Bovine fibrinogen (Armour (Newman, 1964) . Inhibition of streptokinase can the estimated from a standard curve (Fig. 2) 
